NCT02177500View on ClinicalTrials.gov

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

May 31, 2000

Conditions
Hypertension
Interventions
DRUG

Telmisartan + hydrochlorothiazide

DRUG

Telmisartan

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02177500 - Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy | Biotech Hunter | Biotech Hunter